Revvity | PKI - Ebitda





Ebitda Veränderung Datum
Agilent USD 456M 84M 2025-12
Align Technology USD 260.87M 77.03M 2025-12
Bio Techne USD 116.71M 13.29M 2026-03
Bio-Rad Laboratories USD 983.8M 1.36B 2025-12
Bruker USD 110M 101.6M 2026-03
Celltrion KRW 17.79B 356.77B 2025-12
Charles River Laboratories USD 229.8M 28.26M 2026-03
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 129M 6M 2026-03
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 9.34B 440M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Illumina USD 469M 137M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Laboratory Of America USD 605.6M 17.5M 2026-03
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Mesa Laboratories USD 9.58M 1.47M 2024-09
Mettler Toledo International USD 278.99M 100.24M 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Organigram Holdings CAD 5.26M 884K 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Pharma Mar EUR 2.71M 42.25M 2026-03
Qiagen NV USD 249.69M 56.53M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Quidel USD 108.7M 44.6M 2026-03
Repligen USD 40.01M 469K 2026-03
Revvity USD 272.91M 24M 2026-03
Sartorius EUR 267.3M 10.1M 2026-03
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Tilray USD 8.36M 1.82M 2025-09
Waters USD 380.97M 85.83M 2025-12
Zealand Pharma A/S -727.47M 285.54M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03